42 related articles for article (PubMed ID: 31659558)
1. Fabrication of Ibrutinib Nanosuspension by Quality by Design Approach: Intended for Enhanced Oral Bioavailability and Diminished Fast Fed Variability.
Rangaraj N; Pailla SR; Chowta P; Sampathi S
AAPS PharmSciTech; 2019 Oct; 20(8):326. PubMed ID: 31659558
[TBL] [Abstract][Full Text] [Related]
2. Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability.
Rahim H; Sadiq A; Ullah R; Bari A; Amin F; Farooq U; Ullah Jan N; Mahmood HM
Int J Nanomedicine; 2020; 15():8999-9009. PubMed ID: 33235448
[TBL] [Abstract][Full Text] [Related]
3. Herpetetrone nanosuspensions enhance drug solubility and bioavailability to improve anti-hepatic fibrosis effects.
Zhong Y; Hang L; Wang F; Shen B; Shen C; Xue Y; Jia H; Wang L; Yuan H
J Microencapsul; 2023 Dec; 40(8):587-598. PubMed ID: 37733492
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and antitumor activity evaluation of apigenin nanoparticles by the liquid antisolvent precipitation technique.
Wu W; Zu Y; Wang L; Wang L; Wang H; Li Y; Wu M; Zhao X; Fu Y
Drug Deliv; 2017 Nov; 24(1):1713-1720. PubMed ID: 29115900
[TBL] [Abstract][Full Text] [Related]
5.
Shariare MH; Altamimi MA; Marzan AL; Tabassum R; Jahan B; Reza HM; Rahman M; Ahsan GU; Kazi M
Saudi Pharm J; 2019 Jan; 27(1):96-105. PubMed ID: 30662312
[TBL] [Abstract][Full Text] [Related]
6. Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and
Mujtaba MA; Kaleem M; Chaware R; Ingole A; Asiri YI; Hassan MZ; Sabale V; Sabale P; Anwer MK; Mahmood D; Aldawsari MF
ACS Omega; 2024 Apr; 9(14):16346-16357. PubMed ID: 38617636
[TBL] [Abstract][Full Text] [Related]
7. Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs.
Elsebay MT; Eissa NG; Balata GF; Kamal MA; Elnahas HM
Curr Pharm Des; 2023; 29(29):2297-2312. PubMed ID: 37694786
[TBL] [Abstract][Full Text] [Related]
8. Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach.
Kuk DH; Ha ES; Ha DH; Sim WY; Lee SK; Jeong JS; Kim JS; Baek IH; Park H; Choi DH; Yoo JW; Jeong SH; Hwang SJ; Kim MS
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31861173
[TBL] [Abstract][Full Text] [Related]
9. pH-driven entrapment of enrofloxacin in casein-based nanoparticles for the enhancement of oral bioavailability.
Yuan ZX; Deng S; Chen L; Hu Y; Gu J; He L
Food Sci Nutr; 2021 Aug; 9(8):4057-4067. PubMed ID: 34401057
[TBL] [Abstract][Full Text] [Related]
10. FABRICATION AND EVALUATION OF SMART NANOCRYSTALS OF ARTEMISININ FOR ANTIMALARIAL AND ANTIBACTERIAL EFFICACY.
Shah SMH; Ullah F; Khan S; Shah SMM; Isreb M
Afr J Tradit Complement Altern Med; 2017; 14(1):251-262. PubMed ID: 28480403
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and
Khanuja HK; Awasthi R; Dureja H
J Chemother; 2023 Oct; ():1-20. PubMed ID: 37881008
[TBL] [Abstract][Full Text] [Related]
12. Tannic acid coated nanosuspension for oral delivery of chrysin intended for anti-schizophrenic effect in mice.
Salama A; Hamed Salama A; Hasanein Asfour M
Int J Pharm; 2024 May; 656():124085. PubMed ID: 38580073
[TBL] [Abstract][Full Text] [Related]
13. Long-term antitrypanosomal effect of quinapyramine sulphate-loaded oil-based nanosuspension in T. evansi-infected mouse model.
Prayag KS; Paul AT; Ghorui SK; Jindal AB
Drug Deliv Transl Res; 2024 Feb; 14(2):542-554. PubMed ID: 37648938
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation.
Nakarani M; Patel P; Patel J; Patel P; Murthy RS; Vaghani SS
Sci Pharm; 2010; 78(2):345-61. PubMed ID: 21179351
[TBL] [Abstract][Full Text] [Related]
15. The improvement of tyrosol bioavailability by encapsulation into liposomes using pH-driven method.
Yao Y; Ma L; Yu C; Cheng C; Gao H; Wei T; Li L; Wang Z; Liu W; Deng Z; Zou L; Luo T
Food Chem; 2024 Jul; 445():138661. PubMed ID: 38350195
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Anti-Inflammatory Activity of Tilianin Based on the Novel Amorphous Nanocrystals.
Sun M; Guo M; He Z; Luo Y; He X; Huang C; Yuan Y; Zhao Y; Song X; Wang X
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794224
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Comprehensive Evaluation of the Efficacy and Safety of Chlorantraniliprole Nanosuspension.
Ding X; Guo L; Du Q; Wang T; Zeng Z; Wang Y; Cui H; Gao F; Cui B
Toxics; 2024 Jan; 12(1):. PubMed ID: 38251033
[TBL] [Abstract][Full Text] [Related]
18. The investigation of parameters affecting Ibrutinib release from chitosan/tripolyphosphate/carbon nanofiber composite microspheres.
Armutcu C
Turk J Chem; 2022; 46(5):1632-1641. PubMed ID: 37529729
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension.
Sampathi S; Prajapati S; Junnuthula V; Dyawanapelly S
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145695
[TBL] [Abstract][Full Text] [Related]
20. Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects.
Rangaraj N; Sampathi S; Junnuthula V; Kolimi P; Mandati P; Narala S; Nyavanandi D; Dyawanapelly S
Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
